BeyondSpring
BeyondSpring Logo
About BeyondSpring
BeyondSpring Inc. is a clinical-stage biopharmaceutical company specializing in the development of innovative cancer therapies, with a focus on immuno-oncology. Its lead asset, Plinabulin, is being developed for multiple cancer indications, including non-small cell and small cell lung cancer, both as a monotherapy and in combination with other agents. BeyondSpring also advances a pipeline of small molecule immune agents and operates a drug discovery platform, collaborating with partners such as SEED Therapeutics to develop breakthrough therapeutics. The company serves a global market from its headquarters in Florham Park, New Jersey.
Address
100 Campus Drive, 4th Floor, Suite 410 West Side
Florham Park, 07932
United States
Year founded
2014
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
